The US medical devices industry saw a flat growth in overall deal activity during June 2019, when compared with the last 12-month average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
A total of 72 deals worth $6.49bn were announced in June 2019, compared to the 12-month average of 72 deals.
Venture financing was the leading category in the month in terms of volume with 50 deals which accounted for 69.4% of all deals.
In second place was M&A with 18 deals, followed by private equity with four transactions, respectively accounting for 25% and 5.6% of overall deal activity in the country’s medical devices industry during the month.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $5.97bn, while venture financing and private equity deals totalled $515.05m and $3m, respectively.
US medical devices industry deals in June 2019: Top deals
The top five medical devices industry deals accounted for 93.8% of the overall value during June 2019.
The combined value of the top five medical devices industry deals stood at $6.09bn, against the overall value of $6.49bn recorded for the month. The top announced US medical devices industry deal tracked by GlobalData in June 2019 was Dassault Systemes‘ $5.8bn acquisition of Medidata Solutions.
In second place was the $100m venture financing of Acutus Medical by 8VC, Advent Venture Partners, Deerfield ManagementLP, GE Ventures, Opaleye Management, Orbimed Advisors, Pura Vida Investments and Xeraya Capital Sdn and in third place was Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners XII, Providence Ventures, Sanofi Ventures, USVP ManagementLlc and Wellington ManagementLLP’s $73m venture financing of Omada Health.
The $60m acquisition of Orthex and Vilex by OrthoPediatrics and InVitae’s acquisition of Singular Bio for $55m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.